ImageneBio Appoints Matt Robbins as General Counsel with 15 Years Experience
IMA•ImageneBio named Matt Robbins as General Counsel effective July 7, bringing over 15 years of corporate, securities and transactional experience at Bright Peak Therapeutics. He will oversee legal, intellectual property and compliance as the company advances Phase 2 IMG-007 trials in atopic dermatitis and alopecia areata.
1. Appointment Overview
Effective July 7, ImageneBio has appointed Matt Robbins as General Counsel. Robbins brings more than 15 years of corporate, securities and transactional experience to the role.
2. Key Responsibilities
Robbins will lead the company’s legal, intellectual property and compliance functions, providing strategic counsel on governance and transaction matters.
3. Support for IMG-007 Programs
His appointment strengthens the legal infrastructure as ImageneBio advances Phase 2 trials of IMG-007 in moderate-to-severe atopic dermatitis and alopecia areata, with key data readouts expected.
4. Professional Background
Previously General Counsel at Bright Peak Therapeutics, Robbins built its legal function from the ground up. He also spent nearly nine years at Cooley LLP and began his career as a consultant at Deloitte & Touche.
